Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV001526542 | SCV001736967 | pathogenic | Al Kaissi syndrome | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001658236 | SCV001874055 | pathogenic | not provided | 2024-04-25 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect by affecting the cytoskeleton resulting in fewer and shorter cilia (PMID: 29130579); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29130579, 34369103) |
Ambry Genetics | RCV002568129 | SCV003690981 | likely pathogenic | Inborn genetic diseases | 2022-09-05 | criteria provided, single submitter | clinical testing | The c.870_871delAT (p.W291Afs*18) alteration, located in exon 11 (coding exon 11) of the CDK10 gene, consists of a deletion of 2 nucleotides from position 870 to 871, causing a translational frameshift with a predicted alternate stop codon after 18 amino acids. This alteration occurs at the 3' terminus of the CDK10 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 19% of the protein. However, premature stop codons are typically deleterious in nature and a significant portion of the protein is affected (Ambry internal data). This alteration was detected in the homozygous state in one Ashkenazi Jewish individual with Al Kaissi syndrome (Guen, 2018). Functional assays suggest that patient cells have impaired primary cilia morphology and ciliogenesis (Guen, 2018). Based on the available evidence, this alteration is classified as likely pathogenic. |